Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2025
Cardiovascular Risk Factors and Genetic Risk in Transthyretin V142I Carriers, Alanna C Morrison, Bing Yu, Bruce M Psaty, et al.
Phase II Trial of Atezolizumab and Bevacizumab for Treatment of HPV-Positive Unresectable or Metastatic Squamous Cell Carcinoma of the Anal Canal, Van K Morris, Suyu Liu, Kangyu Lin, et al.
Phase 1/2 Trial of Encorafenib, Cetuximab, and Nivolumab in Microsatellite Stable BRAFV600E Metastatic Colorectal Cancer, Van K Morris, Christine M Parseghian, Vahid Bahrambeigi, et al.
Time Dependency for Human Papillomavirus Circulating Tumor DNA Detection after Chemoradiation as a Prognostic Biomarker for Localized Anal Cancer, Van K Morris, Weihong Xiao, Kangyu Lin, et al.
Proceedings of the National Cancer Institute Workshop on Combining Immunotherapy With Radiotherapy: Challenges and Opportunities for Clinical Translation, Zachary S Morris, Sandra Demaria, Arta M Monjazeb, et al.
Identification of Prothrombin Belgrade Variant in a Mexican-American Family with Recurrent Deep Vein Thrombosis, Émile Moura Coelho da Silva, Natalie Montanez, and Miguel Escobar
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Metastatic Variant Histology (Non-Clear Cell) Renal Cell Carcinoma, Mohammad Jad Moussa, Jaanki Khandelwal, Nathaniel R Wilson, et al.
Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary Tract, Mohammad Jad Moussa, Georges C Tabet, Arlene O Siefker-Radtke, et al.
Identification of Therapeutic Targets for Renal Medullary Carcinoma via Integrated Genomic and Transcriptomic Profiling, Pavlos Msaouel, Nizar M Tannir, Funda Meric-Bernstam, et al.
Sitravatinib in Combination With Nivolumab Plus Ipilimumab in Patients With Advanced Clear Cell Renal Cell Carcinoma: A Phase 1 Trial, Pavlos Msaouel, Kai Yu, Ying Yuan, et al.
Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers, Mohd Mughees, Moises Tacam, Alex W Tan, et al.
Preoperative Brain Mapping Predicts Language Outcomes After Eloquent Tumor Resection, Matthew T Muir, Kyle Noll, Sarah Prinsloo, et al.
SARS-CoV-2 RNA-Binding Protein Suppresses Extracellular miRNA Release, Hyejin Mun, Chang Hoon Shin, Qingxuan Fei, et al.
Non-canonical Splice Variants in Thoracic Aortic Dissection Cases and Marfan Syndrome With Negative Genetic Testing, Xue-Yan Duan, Jessica X Chong, Michael J Bamshad, et al.
Early Diagnosis of Vascular Ehlers-Danlos Syndrome Through AI-Powered Facial Analysis: Results From the Montalcino Aortic Consortium, David R Murdock, Adarsh Suresh, Ernesto Calderon Martinez, et al.
Trametinib Decreased Intracerebral Hemorrhages and Endothelial-to-Mesenchymal Transition in KRAS, Ohnmar Myint, Bridger Freeman, Jae Yeong Jeong, et al.
Diet and Survival After a Diagnosis of Ovarian Cancer: A Pooled Analysis From the Ovarian Cancer Association Consortium, Christina M Nagle, Torukiri I Ibiebele, Renhua Na, et al.
Safety and Efficacy of Toripalimab in Patients with Cholangiocarcinoma: An Open-Label, Phase 1 Study, Aung Naing, Amit Mahipal, Milind Javle, et al.
TIGIT Inhibitor M6223 As Monotherapy or in Combination With Bintrafusp Alfa in Patients With Advanced Solid Tumors: A First-in-Human, Phase 1, Dose-Escalation Trial, Aung Naing, Meredith McKean, Anthony Tolcher, et al.
Multiomic Random Forest Toxicity Modeling of Radiation Esophagitis, Saurabh S Nair, Ramon M Salazar, Ting Xu, et al.
Generation of Human Induced Pluripotent Stem Cell Line From a Familial Alzheimer’s Disease Patient Carrying Missense Mutations in PSEN1 and MAPT Genes, Ashaq H Najar, Sofia E Sepulveda, Camila Gherardelli, et al.
Pembrolizumab in Patients with Advanced Miscellaneous Rare Cancers: Results from a Phase 2 Basket Trial, Mirella Nardo, Camila Braganca Xavier, Bettzy Stephen, et al.
Lefitolimod in Combination with Ipilimumab in Patients with Advanced Solid Tumors: A Phase I Trial, Mirella Nardo, Mohamed A Gouda, Matthew J Reilley, et al.
Natural History Models for Lung Cancer: A Scoping Review, Renu Sara Nargund, Sayaka Ishizawa, Maryam Eghbalizarch, et al.
Childhood Trauma and Inflammatory Biomarker Effects on Cortical Thinning in Schizophrenia Spectrum Disorders, Samantha Narvaez, Yizhou Ma, Joshua Chiappelli, et al.